UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden

hours per response:

0.5

1. Name and Address of Reporting Person*PFIZER INC

(Last)

(First)

(Middle)

235 EAST 42ND STREET

(Street)

NEW YORK

NY

10017

(City)

(State)

(Zip)

2. Date of Event Requiring Statement

(Month/Day/Year)

12/28/2007

3. Issuer Name and Ticker or Trading Symbol

Coley Pharmaceutical Group, Inc.

[ COLY ]

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

Director

10% Owner

Officer (give title below)

Other (specify below)

5. If Amendment, Date of Original Filed

(Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr.

4)

2.

Amount of Securities Beneficially Owned (Instr.

4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

4. Nature of Indirect Beneficial Ownership (Instr.

5)

Common stock

24,423,732(1)

See Footnote 2(2)

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr.

4)

2. Date Exercisable and Expiration Date

(Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr.

4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form: Direct (D) or Indirect (I) (Instr.

5)

6. Nature of Indirect Beneficial Ownership (Instr.

5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Explanation of Responses:

1. Includes 23,798,732 shares that were purchased in a tender offer by Corvette Acquisition Corp., including 40,048 shares that are subject to guaranteed delivery procedures.

2. Corvette Acquisition Corp. recently completed a tender offer for all of the outstanding shares of the issuer. Corvette Acquisition Corp. is a wholly-owned subsidiary of Pfizer Vaccines LLC. Pfizer Vaccines LLC is a wholly-owned subsidiary of Pfizer Inc.

Remarks:

This report is being filed by Pfizer Inc. on behalf of itself, its wholly-owned subsidiary Pfizer Vaccines LLC and its indirect wholly-owned

subsidiary Corvette Acquisition Corp. Corvette Acquisition Corp. is a wholly-owned subsidiary of Pfizer Vaccines LLC.

Susan Grant, Assistant Secretary of Pfizer Inc.

01/04/2008

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,

see

Instruction

(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations

See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,

see

Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.